VR Logo

Auro Laboratories Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1989

Chairman: Sharat Deorah

Managing Director: Sharat Deorah

Group: --

Listing: BSE: 530233

Headquarters: Thane, Maharashtra

Website: www.aurolabs.com

Key Facts

Market cap: R 28.20 Cr

Revenue (TTM): R 45.89 Cr

Earnings (TTM): R 5.17 Cr

Cash: R 4.11 Cr

Total Debt: R 8.09 Cr

Promoters' ownership: 51.92%

Liquidity: Moderate

52 Week range: R 23.00 - 64.60

Face value: R10.00

Shares outstanding: 62,32,500

10 Years Aggregate:

  • CFO: 30.88 Cr
  • EBITDA: 33.64 Cr
  • Net Profit: 12.32 Cr

Stock Performance

Time Period Auro Laboratories S&P BSE Healthcare S&P BSE Small Cap
YTD-4.9423.40-6.54
1 month0.221.467.10
3 months-6.7013.8624.38
1 Year-16.2029.91-6.53
3 Years-15.494.43-6.96
5 Years31.36-0.572.46
10 Years27.0111.153.28
As on 10-Jul-2020
Year Auro Laboratories S&P BSE Small Cap S&P BSE Healthcare
2019-15.75-6.85-3.55
2018-25.37-23.41-5.89
2017122.1159.640.49
201634.141.77-12.88
2015232.886.7615.06
20143.7169.2447.43
2013-47.80-11.2322.55